Package 58458-002-02

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 58458-002-02
Digits Only 5845800202
Product NDC 58458-002
Product ID 58458-002_36422686-af0f-a4e1-e063-6294a90a1b44
Description

1 VIAL, GLASS in 1 CARTON (58458-002-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2025-07-30
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "36422686-af0f-a4e1-e063-6294a90a1b44", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["5804d999-96eb-4fd1-b7d8-de7867c5f1d6"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Reliance Life Sciences Private Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (58458-002-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "58458-002-02", "marketing_start_date": "20250730"}], "brand_name": "Azacitidine", "product_id": "58458-002_36422686-af0f-a4e1-e063-6294a90a1b44", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "58458-002", "generic_name": "Azacitidine", "labeler_name": "Reliance Life Sciences Private Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA217453", "marketing_category": "ANDA", "marketing_start_date": "20250730", "listing_expiration_date": "20261231"}